ImprimisRx® offers over 3,500 (over 200 formulations shown here) unique compounded formulations prescribed for many therapeutic areas. We are dedicated to providing medications to patients at affordable prices.
Don’t see what you are looking for? Click here to inquire about a customized formulation not in this list.
| Formulation | Classification | Strength |
|---|---|---|
| Moxi-Brom (Moxifloxacin/Bromfenac)* – 5mL | Topical Medication | 0.5/0.075% |
| Moxifloxacin 0.8mg/0.8mL* – Single-Use Vial | Injectable | 0.8mg/0.8mL (1mg/mL) |
| Moxifloxacin 4mg/0.8mL* – Single-Use Vial | Injectable | 4mg/0.8mL (5mg/mL) |
| Mydriatic 2 (Tropicamide/Phenylephrine)* – Multi-Dose 10 mL | Topical Medication | 1/2.5% |
| Mydriatic 2 (Tropicamide/Phenylephrine)* – Single-Use – 5mL | Topical Medication | 1/2.5% |
| Mydriatic 3 (Tropi-Cyclo-Phenyl)* – 1mL | Topical Medication | 1/1/2.5% |
| Mydriatic 4 (Tropi-Prop-Phenyl-Ketor)* – Multi-Dose – 5mL | Topical Medication | 1/0.5/2.5/0.5% |
| Mydriatic 4 (Tropi-Prop-Phenyl-Ketor)* – Single-Use – 5mL | Topical Medication | 1/0.5/2.5/0.5% |
| Pentosan Polysulfate Sodium* – 150mg | Capsule | 150mg |
| Pentosan Polysulfate Sodium* – 200mg | Capsule | 200mg |
| Phenylephrine/Lidocaine (PF/SF)* – Single Use Vial | Injectable | 1.5/1% |
*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. ImprimisRx® dispenses only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.
Potential Ingredient Risks
Storage: Store at Room Temperature, 20°C to 25°C (68°F to 77°F)
Auxiliary Labeling: Store upright in original bottle.
Moxifloxacin Hydrochloride
Possible Indications: Bacterial Conjunctivitis
Possible Adverse Effects: Conjunctival Irritation, Decreased Visual Acuity, Dysgeusia, Eye Discharge, Eye Irritation, Eye Pain, Eye Redness, Eyelid Edema, Headache, Increased Lacrimation, Keratitis, Papillary Conjunctivitis, Pyrexia, Subconjunctival Hemorrhage, Tearing, Hypersensitivity Reaction
Potential Contraindications/Precautions: Infants, Lactation, Pregnancy
Bromfenac Sodium Sesquihydrate
Possible Indications: Postoperative Ophthalmic Inflammation, Postoperative Ophthalmic Pain
Possible Adverse Effects: Abnormal Sensation in Eyes, Anaphylaxis, Anterior Chamber Eye Hemorrhage, Burning Sensation, Conjunctival Hyperemia, Corneal Erosion, Corneal Perforation, Corneal Thinning, Corneal Ulcer, Epithelial Keratopathy, Eye Irritation, Eye Pain, Eye Pruritus, Eye Redness, Headache, Hypersensitivity Reaction, Iritis, Keratitis, Prolonged Bleeding, Stringing Sensation
Potential Contraindications/Precautions: Lactation, Pregnancy, Pediatric Patients, Corneal Disease, Thrombocytopenia, Rheumatoid Arthritis
